Hep-C Therapy Loan Plan Rolls Out In India
This article was originally published in Scrip
Executive Summary
A young Indian social healthcare venture, Arogya Finance, has linked up with Dr Reddy’s Laboratories, to roll out a financing initiative for the latter's hepatitis C therapy, Resof (sofosbuvir).